Eplerenone and Zoledronic drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Eplerenone (eplerenone) and Zoledronic (zoledronic acid). Common drug interactions include anaemia among females and myalgia among males.

The phase IV clinical study analyzes what interactions people have when they take Eplerenone and Zoledronic. It is created by eHealthMe based on reports of 45 people who take the same drugs from the FDA, and is updated regularly.

What is Eplerenone?

Eplerenone has active ingredients of eplerenone. It is often used in high blood pressure. eHealthMe is studying from 9,979 Eplerenone users. Check the latest studies of Eplerenone.

What is Zoledronic?

Zoledronic has active ingredients of zoledronic acid. eHealthMe is studying from 29,812 Zoledronic users. Check the latest studies of Zoledronic.

On Jul, 13, 2026

45 people who take Eplerenone and Zoledronic together, and have interactions are studied.

Eplerenone and Zoledronic drug interactions.

What are the common drug interactions of Eplerenone and Zoledronic, by gender? *:

female:

Anaemia (lack of blood)
Leukopenia (less number of white blood cells in blood)
Thrombocytopenia (decrease of platelets in blood)
Arthralgia (joint pain)
Back pain
Bone pain
Depression
Headache (pain in head)
Pain in extremity

male:

Myalgia (muscle pain)
Vomiting
Dizziness
Fluid retention (an abnormal accumulation of fluid in the blood)
Headache (pain in head)
Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
Hypophosphataemia (electrolyte disturbance in which there is an abnormally low level of phosphate in the blood)
Hypotension (abnormally low blood pressure)
Influenza like illness
Muscular weakness (muscle weakness)

What are the common drug interactions of Eplerenone and Zoledronic, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

Cardiac arrest
Infusion related reaction

20-29:

Pyrexia (fever)
Arthralgia (joint pain)
Bone pain
Chills (felling of cold)
Cold sweat
Dehydration (dryness resulting from the removal of water)
Dizziness
Fluid retention (an abnormal accumulation of fluid in the blood)
Headache (pain in head)
Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)

30-39:

n/a

40-49:

n/a

50-59:

Plasma cell myeloma (cancer that begins in plasma cells)

60+:

Malaise (a feeling of general discomfort or uneasiness)
Myalgia (muscle pain)
Pain in extremity
Pleural effusion (water on the lungs)
Peripheral swelling
Vomiting
Metastases to bone (cancer spreads to bone)
Arthralgia (joint pain)
Back pain
Bone pain

What are the existing conditions these people have? *

Osteopenia (a condition where bone mineral density is lower than normal): 6 people, 13.33%
Indigestion: 6 people, 13.33%
Cardiomyopathy (weakening of the heart muscle): 6 people, 13.33%
Multiple Myeloma (cancer of the plasma cells): 3 people, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Eplerenone and Zoledronic?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously